Drug Profile
Bazlitoran companion diagnostic - Abbott Laboratories
Latest Information Update: 20 Jan 2023
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported B-cell lymphoma